{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:02:39Z","timestamp":1771372959441,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/ajcp\/aqy084","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T03:55:27Z","timestamp":1534996527000},"page":"53-62","source":"Crossref","is-referenced-by-count":19,"title":["Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population"],"prefix":"10.1093","volume":"151","author":[{"suffix":"Jr","given":"Thomas C","family":"Wright","sequence":"first","affiliation":[{"name":"Department of Pathology, Columbia University, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H","family":"Stoler","sequence":"additional","affiliation":[{"name":"University of Virginia Health System, Charlottesville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Parvu","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences-Diagnostic Systems, Sparks, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Yanson","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences-Diagnostic Systems, Sparks, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Eckert","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences-Diagnostic Systems, Sparks, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Kodsi","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences-Diagnostic Systems, Sparks, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles K","family":"Cooper","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, BD Life Sciences-Diagnostic Systems, Sparks, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"key\n\t\t\t\t2018121010240240800_CIT0001","volume-title":"Cytopathology checklist. CAP Number 1870801. Northwestern Memorial Hospital Laboratories","author":"College of American Pathologists","year":"2017"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0002","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0003","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.ajog.2012.12.003","article-title":"APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results","volume":"208","author":"Stoler","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0004","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1470-2045(05)70086-3","article-title":"Carcinogenicity of human papillomaviruses","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0005","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0006","first-page":"255","article-title":"Human Papillomaviruses","volume":"100B","author":"International Agency for Research on Cancer","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0007","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0008","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/AOG.0000000000001699","article-title":"Practice bulletin No. 168 summary: cervical cancer screening and prevention","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0009","author":"US Food and Drug Administration, Center for Devices and Radiological Health","journal-title":"BD Onclarity HPV Assay (P160037) approval letter, February 12, 2018"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pvr.2016.01.003","article-title":"Clinical and analytical performance of the BD Onclarity HPV assay for detection of CIN2+ lesions on SurePath samples","volume":"2","author":"Ejegod","year":"2016","journal-title":"Papillomavirus Res"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0011","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/JCM.00422-11","article-title":"Evaluation of a new DNA test for detection of carcinogenic human papillomavirus","volume":"49","author":"Castle","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0012","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2018.04.007","article-title":"The Onclarity human papillomavirus trial: design, methods, and baseline results","volume":"149","author":"Stoler","year":"2018","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0013","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0014","volume-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Kurman","year":"2014","edition":"4"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0015","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0016","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1309\/AJCPLCD8TTOMLJTB","article-title":"Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study","volume":"143","author":"Castle","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0017","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2010.04.013","article-title":"Clinical validation of the Cervista HPV HR and 16\/18 genotyping tests for use in women with ASC-US cytology","volume":"118","author":"Einstein","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0018","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ajcp\/aqx091","article-title":"Performance of the cobas HPV test for the triage of atypical squamous cells of undetermined significance cytology in cervical specimens collected in Surepath","volume":"148","author":"Tewari","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0019","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1309\/RNF3C01JKADQCLKP","article-title":"The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays","volume":"127","author":"Stoler","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/AJCPGW1V2BBWMOCX","article-title":"The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study","volume":"137","author":"Stoler","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0021","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2015.06.040","article-title":"A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results","volume":"138","author":"Schiffman","year":"2015","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0022","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kj\u00e6r","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0023","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser cohort study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0024","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsagu\u00e9","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0025","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/ijc.25408","article-title":"Prospective study of human papillomavirus and risk of cervical adenocarcinoma","volume":"127","author":"Dahlstr\u00f6m","year":"2010","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2018121010240240800_CIT0026","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ijc.30152","article-title":"Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix","volume":"139","author":"Castanon","year":"2016","journal-title":"Int J Cancer"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/151\/1\/53\/27083048\/aqy084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T20:01:36Z","timestamp":1571774496000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/151\/1\/53\/5090753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,9,5]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqy084","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,9,5]]}}}